Research at a glance

Safety, impressive results, and long-term effectiveness

Physician and patient surveys that show 90% of the people who use Alpha-Stim® CES and MET devices get significant relief when using it as a form of pain, anxiety, depression, or insomnia treatment. This is supported by over 100 completed independent research studies and published reports, many of which were randomly controlled trials to ensure rigorous testing and clinically validated results on the medical devices. That’s why over 200 Department of Defense (DOD) practitioners and over 92 Veterans Administration (VA) hospitals use Alpha-Stim with military personnel for acute, chronic, and post-traumatic pain, anxiety, depression, and insomnia treatment.

Proven to significantly reduce pain, anxiety, depression, and insomnia

Reduced pain

In a study of severe pain patients, Alpha-Stim significantly reduced pain by an average of 71% after only 5 treatments.1

In a post-traumatic pain study, 56% of patients at 3 months and 85% at 6 months were somewhat or very satisfied with the device.2

Chronic pain patients using Alpha-Stim reported significantly improved functionality than the usual care and sham groups.3

read more pain studies

Reduced anxiety

Eighty-three percent (83%) of the active Alpha-Stim CES group reported a decrease in anxiety of ≥ 50% on the HAM-A from baseline to endpoint of study4

In a study of preoperative anxiety, Alpha-Stim recipients reported significantly less anxiety after one 20 minute application5

Read more anxiety studies

Reduced depression

Alpha-Stim CES recipients reported an 82% decrease in depression after 5 weeks of treatment4

After 6 weeks of treatment, Alpha-Stim users experienced 42.8% improvement8